Welcome to LookChem.com Sign In|Join Free

CAS

  • or

143708-33-2

Post Buying Request

143708-33-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

143708-33-2 Usage

Description

2-(Chloromethyl)-6-methyl-1,3-benzoxazole is a chemical compound with the molecular formula C9H9ClNO. It is a benzoxazole derivative that contains both a chloromethyl and a methyl group. 2-(CHLOROMETHYL)-6-METHYL-1,3-BENZOXAZOLE is known for its unique structure and reactivity, making it a versatile intermediate in the synthesis of other organic compounds.

Uses

Used in Pharmaceutical Industry:
2-(Chloromethyl)-6-methyl-1,3-benzoxazole is used as a building block for the synthesis of various pharmaceutical compounds. Its unique structure and reactivity allow for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 2-(Chloromethyl)-6-methyl-1,3-benzoxazole serves as a key intermediate in the production of agrochemicals. Its properties contribute to the creation of effective compounds for crop protection and pest control.
Used as a Fluorescent Probe:
2-(Chloromethyl)-6-methyl-1,3-benzoxazole is utilized as a fluorescent probe for detecting metal ions. Its ability to fluoresce in the presence of certain metal ions makes it a valuable tool in analytical chemistry and environmental monitoring.
Investigated for Pharmacological Properties:
Research is being conducted to explore the potential pharmacological properties of 2-(Chloromethyl)-6-methyl-1,3-benzoxazole. Its unique structure may offer new avenues for drug discovery and development in various therapeutic areas.

Check Digit Verification of cas no

The CAS Registry Mumber 143708-33-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,7,0 and 8 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 143708-33:
(8*1)+(7*4)+(6*3)+(5*7)+(4*0)+(3*8)+(2*3)+(1*3)=122
122 % 10 = 2
So 143708-33-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H8ClNO/c1-6-2-3-7-8(4-6)12-9(5-10)11-7/h2-4H,5H2,1H3

143708-33-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(chloromethyl)-6-methyl-1,3-benzoxazole

1.2 Other means of identification

Product number -
Other names 2-chloromethyl-6-methylbenzooxazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:143708-33-2 SDS

143708-33-2Relevant articles and documents

COMPOUNDS HAVING PDE9A INHIBITORY ACTIVITY, AND PHARMACEUTICAL USES THEREOF

-

Paragraph 0124-0125, (2021/10/15)

The present invention provides a compound having a specific chemical structure and having PDE9A inhibitory activity, or a pharmaceutically acceptable salt thereof. The present invention provides a composition containing the compound or a pharmaceutically acceptable salt thereof. The present invention provides a pharmaceutical use, for treating or preventing PDE9A-related diseases, of the compound according to the present invention, a salt thereof, and a composition containing the compound or salt. The present invention also provides a method for treating or preventing PDE9A-related diseases, the method comprising administering an effective amount of the compound according to the present invention, a salt thereof, or a composition containing the compound or salt to a subject in need of treatment.

QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

-

Page/Page column 67-68, (2009/12/23)

The invention provides compounds of formula (I) wherein R1, R2, R3, R4, R5, Het1, n, Y and X are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them, a process for preparing pharmaceutical compositions, their use in therapy and intermediates of use in their preparation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 143708-33-2